Literature DB >> 182211

Enveloped viruses as model membrane systems: microviscosity of vesicular stomatitis virus and host cell membranes.

Y Barenholz, N F Moore, R R Wagner.   

Abstract

The fluorescence probe 1,6-diphenyl-1,3,5-hexatriene was used to study and compare the dynamic properties of the hydrophobic region of vesicular stomatitis virus grown on L-929 cells, plasma membrane of L-929 cells prepared by two different methods, liposomes prepared from virus lipids and plasma membrane lipids, and intact L-929 cells. The rate of penetration of the probe into the hydrophobic region of the lipid bilayer was found to be much faster in the lipid vesicle bilayer as compared with the intact membrane, but in all cases the fluorescence anisotropy was constant with time. The L-cell plasma membranes, the vesicles prepared from the lipids derived from the plasma membranes, and intact cells are found to have much lower microviscosity values than the virus or virus lipid vesicles throughout a wide range of temperatures. The microviscosity of plasma membrane and plasma membrane lipid vesicles was found to depend on the procedure for plasma membrane preparation as the membranes prepared by different methods had different microviscosities. The intact virus and liposomes prepared from the virus lipids were found to have very similar microviscosity values. Plasma membrane and liposomes prepared from plasma membrane lipids also had similar microviscosity values. Factors affecting microviscosity in natural membranes and artificially mixed lipid membranes are discussed.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 182211     DOI: 10.1021/bi00661a026

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  19 in total

1.  Expression of the M gene of vesicular stomatitis virus cloned in various vaccinia virus vectors.

Authors:  Y Li; L Z Luo; R M Snyder; R R Wagner
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

2.  Monoclonal antibodies to the M protein of vesicular stomatitis virus (Indiana serotype) and to a cDNA M gene expression product.

Authors:  R Pal; B W Grinnell; R M Snyder; J R Wiener; W A Volk; R R Wagner
Journal:  J Virol       Date:  1985-08       Impact factor: 5.103

3.  Inhibition of transcription by immunoglobulins directed against the ribonucleoprotein of homotypic and heterotypic vesicular stomatitis viruses.

Authors:  A R Carroll; R R Wagner
Journal:  J Virol       Date:  1978-02       Impact factor: 5.103

4.  Interaction of vesicular stomatitis virus with lipid vesicles: depletion of cholesterol and effect on virion membrane fluidity and infectivity.

Authors:  N F Moore; E J Patzer; J M Shaw; T E Thompson; R R Wagner
Journal:  J Virol       Date:  1978-08       Impact factor: 5.103

5.  Role of the membrane (M) protein in endogenous inhibition of in vitro transcription by vesicular stomatitis virus.

Authors:  A R Carroll; R R Wagner
Journal:  J Virol       Date:  1979-01       Impact factor: 5.103

6.  Early molecular events in the interaction of enveloped viruses with cells. I. A fluorescence and radioactivity study.

Authors:  C Nicolau; H D Klenk; K Hildenbrand; B Reimann; A Reimann; H Bauer
Journal:  Biophys Struct Mech       Date:  1979-03-21

7.  Unsaturated free fatty acids inactivate animal enveloped viruses.

Authors:  A Kohn; J Gitelman; M Inbar
Journal:  Arch Virol       Date:  1980       Impact factor: 2.574

8.  Asymmetry of lipid organization in cholinergic synaptic vesicle membranes.

Authors:  D M Michaelson; G Barkai; Y Barenholz
Journal:  Biochem J       Date:  1983-04-01       Impact factor: 3.857

9.  Spatial relationships of the proteins of vesicular stomatitis virus: induction of reversible oligomers by cleavable protein cross-linkers and oxidation.

Authors:  E J Dubovi; R R Wagner
Journal:  J Virol       Date:  1977-05       Impact factor: 5.103

10.  Regulation of viral transcription by the matrix protein of vesicular stomatitis virus probed by monoclonal antibodies and temperature-sensitive mutants.

Authors:  R Pal; B W Grinnell; R M Snyder; R R Wagner
Journal:  J Virol       Date:  1985-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.